General Information of Drug (ID: DMQ8AD4)

Drug Name
OSSM-001
Indication
Disease Entry ICD 11 Status REF
Crohn disease DD70 Phase 1 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
DAD62Z

References

1 ClinicalTrials.gov (NCT05407766) A Phase I Safety Study of Allogeneic Bone Marrow Derived MSCs for Refractory Perianal Fistulizing Crohn's Disease. U.S.National Institutes of Health.